Fig. 1From: The immune checkpoint regulator PD-L1 expression are associated with clinical progression in prostate cancerRepresentative immunohistochemical (IHC) staining of PD1 and PDL1 in prostate cancer tissues. A, C Representative images showing PD-1 expression in tumour epithelial cells and lymphocytes, respectively. B, D Representative images showing PD-L1 expression in tumour epithelial cells and lymphocytes, respectively. Original magnification, × 400. PD-1, programmed cell death protein 1; PD-L1, programmed death-ligand 1Back to article page